Skip to search formSkip to main contentSkip to account menu

Lescol

National Institutes of Health

Related topics

Related topics

4 relations
24 HR fluvastatin 80 MG Extended Release Oral Tablet [Lescol]fluvastatin 40 MG Oral Capsule [Lescol]

Broader (2)

Fluvastatin sodiumfluvastatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study
Background Despite improvements in kidney transplantation, complications, including cardiovascular morbidity and graft loss… 
2010
2010
Comparison of predictive ability of lipoprotein components to that of traditional risk factors of coronary events in renal transplant recipients.
2006
2006
Fluvastatin (lescol) treatment of hyperlipidaemia in patients with renal transplants
Hyperlipidaemia of 18 male and 20 female patients following successful renal transplantation was treated with daily 20 mg… 
Highly Cited
2005
Highly Cited
2005
Renal Dysfunction as a Risk Factor for Mortality and Cardiovascular Disease in Renal Transplantation: Experience from the Assessment of Lescol in Renal Transplantation Trial
Background. Renal-transplant recipients have shortened life expectancy primarily because of premature cardiovascular disease… 
2005
2005
Does time of onset of therapy alter the protective cardiovascular effect of fluvastatin after renal transplantation?
Does time of onset of therapy alter the protective cardiovascular effect of fluvastatin after renal transplantation? 
2004
2004
No Detrimental Effect On Renal Function During Long-term Use Of Fluvastatin
2003
2003
1302 Fluvastatin for the prevention of cardiac events following successful first percutaneous coronary intervention: analysis of cost-effectiveness based on the lescol intervention prevention study…
2003
2003
Clinical observation of lescol on primary hyperchole sterolemia
Objective: To explore the clinical efficacy and treatment mechanism of Lescol (fluvastatin) in the treatment of primary… 
2001
2001
P-246: Lack of steady-state pharmacokinetic interaction of lescol XL® 80 mg and Norvasc® 5 mg in healthy subjects
1995
1995
Fluvastatin (Sandoz compound XU 62-320- lescol), an HMG-CoA reductase inhibitor, in treatment of patients with type II a hyperlipidemia — Its efficacy and safety
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)